What is the recommended pediatric dosing for amoxicillin/clavulanate potassium suspension (600 mg amoxicillin + 42.9 mg clavulanate potassium per 5 mL)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Amoxicillin-Clavulanate 600-42.9 mg/5 mL Pediatric Dosing

The amoxicillin-clavulanate 600 mg/42.9 mg per 5 mL suspension (14:1 ratio) should be dosed at 90 mg/kg/day of the amoxicillin component, divided into two doses given every 12 hours, with a maximum single dose of 4000 mg amoxicillin. This high-dose formulation is specifically designed for enhanced coverage against resistant pathogens, particularly β-lactamase-producing Haemophilus influenzae and penicillin-resistant Streptococcus pneumoniae 1.

Specific Dosing Parameters

Standard Dosing

  • Dose: 90 mg/kg/day (based on amoxicillin component)
  • Frequency: Every 12 hours (twice daily)
  • Duration: Typically 5-10 days depending on indication 1
  • Administration: Can be given with or without food, though absorption of clavulanate is enhanced when taken at the start of a meal 1

Age-Specific Considerations

Infants < 3 months: This formulation is not recommended. Use the 125 mg/31.25 mg per 5 mL suspension at 30 mg/kg/day divided every 12 hours instead 1.

Children ≥ 3 months: The 600-42.9 mg/5 mL formulation is appropriate and provides the 14:1 ratio of amoxicillin to clavulanate, which minimizes gastrointestinal side effects (particularly diarrhea) compared to lower ratio formulations 1.

Children ≥ 40 kg: Should transition to adult tablet dosing rather than suspension 1.

Clinical Indications for High-Dose Formulation

This specific high-dose formulation (90/6.4 mg/kg/day) is indicated for 2, 3, 2, 3:

  • β-lactamase-producing Haemophilus influenzae infections (respiratory tract)
  • Recurrent or persistent acute otitis media after initial amoxicillin failure
  • Moderate to severe infections in children < 2 years
  • Recent antibiotic exposure (within 30 days)
  • Day care attendance (higher risk of resistant organisms)
  • Acute bacterial sinusitis requiring enhanced coverage 4

Evidence-Based Efficacy

The 90/6.4 mg/kg/day regimen demonstrates superior bacteriologic eradication rates 5:

  • 98% eradication of S. pneumoniae (including 91% of penicillin-resistant strains with MICs 2-4 μg/mL)
  • 94% eradication of H. influenzae
  • 89% clinical cure or improvement in children with documented bacterial infections

Recent data from India confirms excellent safety and efficacy, with 82.8% clinical cure rates and only 6.3% experiencing diarrhea 6.

Safety and Tolerability

Common adverse events (generally mild and self-limiting):

  • Diarrhea: 6.3-12% (significantly lower with twice-daily vs. three-times-daily dosing) 6, 7
  • Gastrointestinal disturbances: Most common adverse effect
  • No serious adverse events reported in large pediatric studies 7

Important caveat: This formulation contains aspartame and should NOT be used in phenylketonuric patients 1.

Practical Dosing Example

For a 15 kg child:

  • Total daily dose: 15 kg × 90 mg/kg = 1350 mg amoxicillin
  • Per dose (every 12 hours): 675 mg amoxicillin
  • Volume per dose: 675 mg ÷ 120 mg/mL = 5.6 mL every 12 hours

Critical Distinctions

Do NOT substitute this formulation with other amoxicillin-clavulanate preparations 1:

  • The 600-42.9 mg/5 mL (14:1 ratio) is NOT interchangeable with 250-62.5 mg/5 mL (4:1 ratio)
  • Two doses of lower-strength formulations do NOT equal one dose of high-dose formulation due to different clavulanate content
  • The 14:1 ratio specifically maintains therapeutic amoxicillin levels while minimizing clavulanate-related diarrhea

Special Populations

Renal impairment: Dose adjustment required for severe impairment (GFR < 30 mL/min), though this is rare in pediatrics 1.

Critically ill children post-cardiac surgery: May require 4-hourly dosing due to augmented clearance, unless receiving vasopressors 8.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.